News
U.S. Secures An Additional 100 Million Doses of Pfizer Vaccine

Millions of Americans are expected to be vaccinated from COVID-19 by the fall at no cost to them thanks to a new deal with Pfizer and BioNTech. The Department of Health and Human Services announced the update on Wednesday.
The agreement includes the purchase of 100 million additional doses of their coronavirus vaccine, which is projected to be fully delivered by July 31, 2021. It is expected that 70 million of the 100 million doses purchased will be delivered by June 30, 2021.
The deal contains options for the U.S. government to purchase an additional 400 million doses of their coronavirus vaccine if they choose.
Moderna is the only other company so far whose vaccine has received emergency authorization from the FDA. They have agreed to supply the U.S. government with 200 million doses by June 2021.
Both the Pfizer and Moderna vaccines require two doses approximately 28 days apart to be fully effective.
In addition to Pfizer and Moderna, Johnson & Johnson has promised 100 million doses to the U.S.; AstraZeneca 100 million doses; Novavax 100 million; and Sanofi/GlaxoSmithKline 100 million. Distribution of these vaccines will remain on hold until treatment is authorized by the FDA.
Enjoy this piece?
… then let us make a small request. The New Civil Rights Movement depends on readers like you to meet our ongoing expenses and continue producing quality progressive journalism. Three Silicon Valley giants consume 70 percent of all online advertising dollars, so we need your help to continue doing what we do.
NCRM is independent. You won’t find mainstream media bias here. From unflinching coverage of religious extremism, to spotlighting efforts to roll back our rights, NCRM continues to speak truth to power. America needs independent voices like NCRM to be sure no one is forgotten.
Every reader contribution, whatever the amount, makes a tremendous difference. Help ensure NCRM remains independent long into the future. Support progressive journalism with a one-time contribution to NCRM, or click here to become a subscriber. Thank you. Click here to donate by check.
![]() |